Guiding immunotherapy based on the oxford classification activity score in IgA nephropathy - Takeaways - MDSpire

Guiding immunotherapy based on the oxford classification activity score in IgA nephropathy

  • By

  • Jingjing Nong

  • Yuhong Tang

  • Jiazhen Yang

  • Wenli Wei

  • Licong Su

  • Sheng Nie

  • Jun Ou

  • June 23, 2026

  • 0 min

Share

  • 1

    The study analyzed 2,389 patients with IgA nephropathy to evaluate the role of Oxford classification activity scores in immunotherapy management.

  • 2

    Immunotherapy was associated with a 22% increase in proteinuria remission at 12 months for patients with IgA nephropathy.

  • 3

    High SumMEC scores indicated a positive response to immunotherapy, while lower scores did not show the same benefit.

  • 4

    The Oxford classification system includes M, E, S, and T features, with recent studies suggesting the importance of M, E, and C lesions.

  • 5

    The study highlights the need for composite scoring systems like SumMEC to better assess immunotherapy responsiveness in IgA nephropathy.

Original Source(s)

Related Content